Pentwater Capital Management’s Aimmune Therapeutics AIMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,501,200
Closed -$86.2M 310
2020
Q3
$86.2M Buy
+2,501,200
New +$53.3M 1.74% 19